Pictor announces funding round after successful launch in New Zealand ...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 20, 2024

Island Fin Poké Co. Celebrates Earth Day by Sharing Its Sustainable Efforts Toward a Greener Earth • Clarification of Details Regarding Oceansix's Engagement with RB Milestone Group LLC • Divert Announces Purchase of New Site in Lexington, North Carolina for Future Integrated Diversion & Energy Facility • USAA to Gift Vehicles to Military and Their Families in 2024 • Boys & Girls Clubs of the Valley and Ross Stores Celebrated 10-Year Anniversary of "Help Local Kids Thrive" In-Store Fundrai • Prime Minister announces appointment of the next Commissioner of the Northwest Territories • T2EARTH Celebrates Earth Day by Leading the Wood Products Industry towards a Sustainable Built Environment • El Car Wash Partners With “CARD” to Support Neurodiversity in the Workplace • University of Phoenix College of Nursing Faculty Leadership Selected for Prestigious Fellows of the American Association of Nurs • ITC Limited - Hip Hop Hacked! Savlon Swasth India Mission's #HandwashLegends made Handwashing cool for India's Youth • Coming into Force of Algonquins of Pikwakanagan First Nation's Child and Family Services Law, Nigig Nibi Ki-win • Energy Transition Accelerator Advances with New Secretariat, Expert Consultative Group • T2EARTH Launches Official YouTube Channel – T2EARTH Talks • Kellanova and Shaw's join No Kid Hungry to help end summer hunger for kids and families in Maine • University of Phoenix College of Doctoral Studies Releases White Paper on How Organizations Can Improve Workplace Wellness Throu • Eaton to announce first quarter 2024 earnings on April 30, 2024 • Engel & Völkers Dallas Fort Worth Presents $20,824 to Special Olympics • Statement from the Minister of Indigenous Services on the preliminary findings from the United Nations Special Rapporteur on the • LS Cable & System Welcomes $99 Million Investment Tax Credit Under Section 48C of the Inflation Reduction Act • Strengthening Canadian research and innovation

Pictor announces funding round after successful launch in New Zealand and USA of SARS-CoV-2 Antibody Test

AUCKLAND, New Zealand , December 04 /Businesswire/ - Pictor, a global leader in immunodiagnostics, today announced a funding round to help accelerate pipeline product development projects along with market development activities within Australia/New Zealand, the US and Europe for its Human Health and Animal Health portfolios.

This follows the recent successful launch of the PictArray™ SARS-CoV-2 IgG Antibody Test through Rako Science in New Zealand and key partners in the US. “The test better informs patients and doctors in determining whether the patient should be immunized or boosted,” said Pictor’s Chief Medical Officer Tadd Lazarus, MD.

Pictor’s multiplex technology enables two key different approaches – testing for multiple diseases or testing for different stages/multiple markers of a disease, all within a single enzyme-linked immunosorbent assay (ELISA) test well. This can provide both greater sensitivity (accuracy), higher throughput and cost efficiencies.

Within the Human Health space, Pictor’s current focus is expanding access to its highly accurate tests for COVID-19 antibodies and accelerating the development of its test for tropical fevers. Pictor has also leveraged its multiplex platform to develop an Animal Health business and is poised to launch two tests in Q2, 2023. The PictArray™ Mycoplasma bovis (M. bovis) and PictArray™ Johne’s Disease tests, developed with support from the Ministry for Primary Industries’ Sustainable Food and Fibre Futures fund, will enable more accurate and effective dairy and beef herd management both in New Zealand and internationally.

In announcing the financing, Pictor CEO Howard Moore said: “This funding round provides a potential opportunity for investors to realize a significant increase in value through the near-term commercialization of our current pipeline, along with acceleration of future product development projects.”

Former Morrison & Co. CEO Marko Bogoievski is helping lead the current funding round following his investment and involvement in Pictor since early 2022.

About Pictor

Pictor is an in vitro diagnostics company that offers a patented multiplexed platform for highly accurate and efficient testing of complex and infectious diseases for human and animal health. PictArray™ multiplexed technology makes it possible to test multiple disease markers in a single test simultaneously — with higher sensitivity, faster throughput, and reduced turn-around time. The company’s lead product, the PictArray™ SARS-CoV-2 IgG ELISA Kit, enables more informed clinical intervention to manage the threat of COVID-19. For more information, please visit http://pictordx.com, https://www.linkedin.com/company/pictorltd and @PictorLtd on Twitter or Facebook.

About Marko Bogoievski

Known as a high-conviction investor, Marko Bogoievski served as the chief executive officer of New Zealand-based Morrison & Co before stepping-down in December 2021. His career saw him lead Morrison & Co to become a global leader in infrastructure investment, specifically focused on data, renewable energy and healthcare. In his thirteen-year tenure with Morrison & Co, Bogoievski led growth in funds under management to over US$20 billion